{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:46:08Z","timestamp":1780616768000,"version":"3.54.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ando.2025.101697","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T16:23:11Z","timestamp":1736871791000},"page":"101697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Chapter 8: Management of aggressive forms of primary HPT: Parathyroid carcinoma and atypical parathyroid tumor"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1617-0149","authenticated-orcid":false,"given":"Christine","family":"Do Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Christou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Hadoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9sir\u00e9e","family":"Deandreis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2025.101697_bib0370","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3390\/cancers14061426","article-title":"Parathyroid carcinoma: incidence, survival analysis, and management: a study from the SEER database and insights into future therapeutic perspectives","volume":"14","author":"Ullah","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ando.2025.101697_bib0375","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1007\/s00432-021-03576-9","article-title":"Epidemiology and prognosis of parathyroid carcinoma: real-world data using nationwide cohort","volume":"147","author":"Kong","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ando.2025.101697_bib0380","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.3390\/jcm12196297","article-title":"Parathyroid retrospective analysis of neoplasms incidence (pTRANI study): an Italian multicenter study on parathyroid carcinoma and atypical parathyroid tumour","volume":"12","author":"Gurrado","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.ando.2025.101697_bib0385","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.amjsurg.2010.09.025","article-title":"Incidence and prognosis of parathyroid gland carcinoma: a population-based study in The Netherlands estimating the preoperative diagnosis","volume":"202","author":"Schaapveld","year":"2011","journal-title":"Am J Surg"},{"key":"10.1016\/j.ando.2025.101697_bib0390","doi-asserted-by":"crossref","first-page":"103664","DOI":"10.1016\/j.esmoop.2024.103664","article-title":"Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"9","author":"Hadoux","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.ando.2025.101697_bib0395","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1210\/clinem\/dgad455","article-title":"Approach to the patient with parathyroid carcinoma","volume":"109","author":"Cetani","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101697_bib0400","doi-asserted-by":"crossref","first-page":"e220287","DOI":"10.1530\/ERC-22-0287","article-title":"Diagnosis and management of parathyroid carcinoma: a state-of-the-art review","volume":"30","author":"Roser","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2025.101697_bib0405","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/humu.23337","article-title":"Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma","volume":"38","author":"Cardoso","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ando.2025.101697_bib0410","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2025.101697_bib0415","doi-asserted-by":"crossref","first-page":"557050","DOI":"10.3389\/fendo.2020.557050","article-title":"Prevalence of parathyroid carcinoma and atypical parathyroid neoplasms in 153 patients with multiple endocrine neoplasia type 1: case series and literature review","volume":"11","author":"Song","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ando.2025.101697_bib0420","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/humu.23337","article-title":"Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma","volume":"38","author":"Cardoso","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ando.2025.101697_bib0425","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s12105-020-01281-6","article-title":"Distinguishing parathyromatosis, atypical parathyroid adenomas, and parathyroid carcinomas utilizing histologic and clinical features","volume":"15","author":"Schulte","year":"2021","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.ando.2025.101697_bib0430","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3346\/jkms.2012.27.8.890","article-title":"Preoperative predictive factors for parathyroid carcinoma in patients with primary hyperparathyroidism","volume":"27","author":"Bae","year":"2012","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ando.2025.101697_bib0435","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1373\/clinchem.2007.085506","article-title":"An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma","volume":"53","author":"Rubin","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.ando.2025.101697_bib0440","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/EJE-08-0169","article-title":"Human chorionic gonadotropin measurements in parathyroid carcinoma","volume":"159","author":"Rubin","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2025.101697_bib0445","first-page":"251","article-title":"Nonfunctional parathyroid carcinoma","volume":"93","author":"Giessler","year":"2001","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.ando.2025.101697_bib0450","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1245\/s10434-010-1003-6","article-title":"Clinical presentation, staging and long-term evolution of parathyroid cancer","volume":"17","author":"Talat","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ando.2025.101697_bib0455","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s40618-016-0447-3","article-title":"Update on parathyroid carcinoma","volume":"39","author":"Cetani","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2025.101697_bib0460","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of the 2022 WHO classification of parathyroid tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.ando.2025.101697_bib0465","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.humpath.2020.07.008","article-title":"Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: recommendations from the International Collaboration on Cancer Reporting","volume":"110","author":"Williams","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ando.2025.101697_bib0470","doi-asserted-by":"crossref","first-page":"e92061","DOI":"10.1172\/jci.insight.92061","article-title":"Genomic profiling reveals mutational landscape in parathyroid carcinomas","volume":"2","author":"Pandya","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.ando.2025.101697_bib0475","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1002\/ijc.33166","article-title":"The genomic profile of parathyroid carcinoma based on whole-genome sequencing","volume":"147","author":"Hu","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ando.2025.101697_bib0480","doi-asserted-by":"crossref","first-page":"znae108","DOI":"10.1093\/bjs\/znae108","article-title":"Consensus statement of the European Society of Endocrine Surgeons (ESES) on advanced parathyroid cancer: definitions and management","volume":"111","author":"Makay","year":"2024","journal-title":"Br J Surg"},{"key":"10.1016\/j.ando.2025.101697_bib0485","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3390\/cancers11111676","article-title":"Parathyroid cancer: a review","volume":"11","author":"Machado","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ando.2025.101697_bib0490","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.21037\/qims.2019.07.02","article-title":"Semi-quantitative analysis of 99mTc-sestamibi retention level for preoperative differential diagnosis of parathyroid carcinoma","volume":"9","author":"Zhang","year":"2019","journal-title":"Quant Imaging Med Surg"},{"key":"10.1016\/j.ando.2025.101697_bib0495","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejrad.2017.07.026","article-title":"The diagnostic accuracy of neck ultrasound, 4D-Computed tomographyand sestamibi imaging in parathyroid carcinoma","volume":"95","author":"Christakis","year":"2017","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ando.2025.101697_bib0500","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/RLU.0000000000001652","article-title":"18F-fluorocholine, 18F-FDG, and 18F-fluoroethyl tyrosine PET\/CT in parathyroid cancer","volume":"42","author":"Hatzl","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ando.2025.101697_bib0505","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/cen.14088","article-title":"Minimally invasive parathyroid carcinoma\u00a0\u2013\u00a0a missing entity between parathyroid adenoma and carcinoma: scintigraphic and histological features","volume":"91","author":"Singh","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2025.101697_bib0510","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00259-015-3130-6","article-title":"18 Fluorocholine PET\/CT in parathyroid carcinoma: a new tool for disease staging?","volume":"42","author":"Deandreis","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ando.2025.101697_bib0515","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/jamaoto.2019.2352","article-title":"Transnasal-transpterygoid endoscopic removal of an 18F-choline-avid parathyroid carcinoma metastasis in the skull base","volume":"145","author":"Morand","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ando.2025.101697_bib0520","doi-asserted-by":"crossref","first-page":"102012","DOI":"10.1016\/j.ctrv.2020.102012","article-title":"Parathyroid cancer: an update","volume":"86","author":"Rodrigo","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ando.2025.101697_bib0525","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1210\/jc.2007-0585","article-title":"Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma","volume":"92","author":"Silverberg","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101697_bib0530","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s00774-016-0797-0","article-title":"Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism","volume":"35","author":"Takeuchi","year":"2017","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.ando.2025.101697_bib0535","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1007\/s00268-010-0722-y","article-title":"Lymph node involvement and surgical approach in parathyroid cancer","volume":"34","author":"Schulte","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2025.101697_bib0540","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000491039","article-title":"Parathyroid carcinoma","volume":"51","author":"Cetani","year":"2019","journal-title":"Front Horm Res"},{"key":"10.1016\/j.ando.2025.101697_bib0545","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/SMJ.0b013e318073ca37","article-title":"Multiglandular parathyroid carcinoma: a case report and brief review","volume":"100","author":"Sahasranam","year":"2007","journal-title":"South Med J"},{"key":"10.1016\/j.ando.2025.101697_bib0550","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1245\/s10434-020-08825-8","article-title":"The use and benefit of adjuvant radiotherapy in parathyroid carcinoma: a national cancer database analysis","volume":"28","author":"Limberg","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ando.2025.101697_bib0555","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1016\/j.prro.2017.05.009","article-title":"Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: the MD Anderson experience of 35 years","volume":"7","author":"Christakis","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ando.2025.101697_bib0560","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hed.20049","article-title":"Parathyroid carcinoma: a 22-year experience","volume":"26","author":"Busaidy","year":"2004","journal-title":"Head Neck"},{"key":"10.1016\/j.ando.2025.101697_bib0565","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/cncr.11819","article-title":"Parathyroid carcinoma: is there a role for adjuvant radiation therapy?","volume":"98","author":"Munson","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ando.2025.101697_bib0570","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1245\/s10434-015-4672-3","article-title":"Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the national cancer data base (NCDB)","volume":"22","author":"Asare","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ando.2025.101697_bib0575","doi-asserted-by":"crossref","first-page":"997009","DOI":"10.3389\/fonc.2022.997009","article-title":"Treatment and outcome of metastatic parathyroid carcinoma: a systematic review and pooled analysis of published cases","volume":"12","author":"Alberti","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ando.2025.101697_bib0580","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ando.2025.101697_bib0585","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1530\/EC-19-0260","article-title":"Somatostatin receptor expression in parathyroid neoplasms","volume":"8","author":"Storvall","year":"2019","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ando.2025.101697_bib0590","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13019-021-01477-z","article-title":"Debulking surgery for functional pleural dissemination of parathyroid carcinoma-case report","volume":"16","author":"Kawagishi","year":"2021","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.ando.2025.101697_bib0595","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/19714009231212361","article-title":"Parathyroid carcinoma: Imaging features of initial presentation and recurrence. A single center experience","volume":"37","author":"Eldaya","year":"2024","journal-title":"Neuroradiol J"},{"key":"10.1016\/j.ando.2025.101697_bib0600","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fendo.2019.00731","article-title":"The clinicopathological spectrum of parathyroid carcinoma","volume":"10","author":"Akirov","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ando.2025.101697_bib0605","first-page":"16","article-title":"Diagnosis and treatment challenges of parathyroid carcinoma in a 27-year-old woman with multiple lung metastases","volume":"2017","author":"Rozhinskaya","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.ando.2025.101697_bib0610","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11864-011-0171-3","article-title":"Parathyroid carcinoma: update and guidelines for management","volume":"13","author":"Wei","year":"2012","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ando.2025.101697_bib0615","doi-asserted-by":"crossref","first-page":"e10114","DOI":"10.1002\/jbm4.10114","article-title":"Recurrent metastasized parathyroid carcinoma-long-term remission after combined treatments with surgery, radiotherapy, cinacalcet, zoledronic acid, and temozolomide","volume":"3","author":"Storvall","year":"2019","journal-title":"JBMR Plus"},{"key":"10.1016\/j.ando.2025.101697_bib0620","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1210\/js.2019-00175","article-title":"MGMT promoter methylation and parathyroid carcinoma","volume":"3","author":"Storvall","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.ando.2025.101697_bib0625","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12020-019-02136-z","article-title":"Long-term remission of disseminated parathyroid cancer following immunotherapy","volume":"67","author":"Sarquis","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2025.101697_bib0630","doi-asserted-by":"crossref","first-page":"643328","DOI":"10.3389\/fendo.2021.643328","article-title":"Case report: abdominal lymph node metastases of parathyroid carcinoma: diagnostic workup, molecular diagnosis, and clinical management","volume":"12","author":"Lenschow","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ando.2025.101697_bib0635","doi-asserted-by":"crossref","first-page":"e235293","DOI":"10.1136\/bcr-2020-235293","article-title":"Microsatellite instability driven metastatic parathyroid carcinoma managed with the anti-PD1 immunotherapy, pembrolizumab","volume":"13","author":"Park","year":"2020","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ando.2025.101697_bib0640","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1634\/theoncologist.2018-0334","article-title":"Genomic profiling of parathyroid carcinoma reveals genomic alterations suggesting benefit from therapy","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.ando.2025.101697_bib0645","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4183\/aeb.2016.383","article-title":"Clinical significance OF PD-L1 expression in parathyroid cancer","volume":"12","author":"Du","year":"2016","journal-title":"Acta Endocrinol (Buchar)"},{"key":"10.1016\/j.ando.2025.101697_bib0650","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/1878-0261.13398","article-title":"Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling","volume":"17","author":"Teleanu","year":"2023","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ando.2025.101697_bib0655","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ijc.31948","article-title":"Preliminary exploration of potential molecular therapeutic targets in recurrent and metastatic parathyroid carcinomas","volume":"144","author":"Cui","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ando.2025.101697_bib0660","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jss.2022.08.017","article-title":"Parathyroid carcinoma: a national cancer database analysis","volume":"281","author":"Goldner","year":"2023","journal-title":"J Surg Res"},{"key":"10.1016\/j.ando.2025.101697_bib0665","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-0043-109562","article-title":"Parathyroid hormone levels predict long-term outcome after operative management of parathyroid cancer","volume":"49","author":"Machens","year":"2017","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ando.2025.101697_bib0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamcollsurg.2017.01.060","article-title":"Prognostic scoring system to risk stratify parathyroid carcinoma","author":"Silva-Figueroa","year":"2017","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ando.2025.101697_bib0675","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1245\/s10434-021-10962-7","article-title":"Extended en bloc reoperation for recurrent or persistent parathyroid carcinoma: analysis of 31 cases in a single institute experience","volume":"29","author":"Wei","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ando.2025.101697_bib0680","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s40618-020-01224-6","article-title":"Immunocyte density in parathyroid carcinoma is correlated with disease recurrence","volume":"43","author":"Hu","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2025.101697_bib0685","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s12020-024-03687-6","article-title":"The significance of an immunohistochemical marker-based panel in assisting the diagnosis of parathyroid carcinoma","volume":"84","author":"Hu","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2025.101697_bib0690","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<538::AID-CNCR25>3.0.CO;2-K","article-title":"Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a national cancer data base report. The American College of Surgeons Commission on Cancer and the American Cancer Society","volume":"86","author":"Hundahl","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ando.2025.101697_bib0695","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1210\/jc.2011-1571","article-title":"Parathyroid carcinoma: a 43-year outcome and survival analysis","volume":"96","author":"Harari","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101697_bib0700","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.surg.2014.08.069","article-title":"Parathyroid carcinoma in more than 1,000 patients: a population-level analysis","volume":"156","author":"Sadler","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2025.101697_bib0705","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.surg.2014.05.014","article-title":"Prognostic factors and staging systems in parathyroid cancer: a multicenter cohort study","volume":"156","author":"Villar-del-Moral","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2025.101697_bib0710","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1245\/s10434-018-6559-6","article-title":"Tumor size and presence of metastatic disease at diagnosis are associated with disease-specific survival in parathyroid carcinoma","volume":"25","author":"Lo","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ando.2025.101697_bib0715","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4158\/EP-2018-0538","article-title":"The influence of surgical extent and parafibromin staining on the outcome of parathyroid carcinoma: 20-year experience from a single institute","volume":"25","author":"Hu","year":"2019","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ando.2025.101697_bib0720","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1210\/clinem\/dgab452","article-title":"Do patients with atypical parathyroid adenoma need close follow-up?","volume":"106","author":"Saponaro","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2025.101697_bib0725","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.3390\/ijms23136981","article-title":"Immunohistochemical profile of parathyroid tumours: a comprehensive review","volume":"23","author":"Uljanovs","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ando.2025.101697_bib0730","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","article-title":"Parafibromin-deficient (HPT-JT type, CDC73 mutated) parathyroid tumors demonstrate distinctive morphologic features","volume":"43","author":"Gill","year":"2019","journal-title":"Am J Surg Pathol"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426625000162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426625000162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T20:10:33Z","timestamp":1740514233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426625000162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0003426625000162"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2025.101697","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chapter 8: Management of aggressive forms of primary HPT: Parathyroid carcinoma and atypical parathyroid tumor","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2025.101697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101697"}}